Friday, July 17, 2020

Second University of Minnesota study shows no hydroxychloroquine benefit in COVID-19 fight

https://www.startribune.com/second-u-study-shows-no-hydroxychloroquine-benefit-in-covid-19-fight/571791202/

 
An anti-malaria drug that doctors hoped would work against COVID-19, and that President Donald Trump championed and said he took himself, has failed to show substantial benefit in a second University of Minnesota trial.
U researchers compared 491 people with early symptoms of COVID-19 — with one group taking hydroxychloroquine for five days and the other taking a non-medicating placebo — and found no measurable differences in their outcomes.
Death rates of .4% were identical in the groups. Hospitalizations and persistent symptoms over 14 days were slightly more common in the placebo group, but not by a significant difference. Mostly mild side effects such as nausea were reported by 43% of patients taking the drug vs. 22% taking placebos.

The study adds to a volume of evidence that discourages the use of hydroxychloroquine to treat COVID-19 — including the first trial result that the U published in the New England Journal of Medicine last month that showed that the drug offered no protection for people who likely had been exposed to the virus and were at risk for infection.

3 comments :

  1. Oh!

    So Pharma can now make millions! and meanwhile continue killing thousands worldwide .

    Lies Lies Lies!!!

    https://www.youtube.com/watch?v=cPS0qpH9Er0&list=LL&index=11&t=0s

    ReplyDelete
  2. who do you think produces HCQ?
    You don't understand that it's a dead duck. It doesn't work with this virus.
    Dexamethasone, which is cheap, abundant and not patent protected is effective. Why are you fixated on just HCQ? Let go of it.

    ReplyDelete
  3. Pharma sold millions of doses of this placebo called HCQ to the US govt. If it had proven successful in trials, they would have sold a lot more of it too.

    ReplyDelete

ANONYMOUS COMMENTS WILL NOT BE POSTED!
please use either your real name or a pseudonym.